Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors-Reference-Cited by-同舟云学术

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors

Published:1996-08 Issue:9027 Volume:348 Page:573-577
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Socié Gérard,Mary Jean-Yves,de Gramont Aimery,Rio Bernard,Leporrier Michel,Rose Christian,Heudier Phillippe,Rochant Henry,Cahn Jean-Yves,Gluckman Eliane

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Paroxysmal nocturnal hemoglobinuria;Rotoli;Semin Hematol,1989

2. Paroxysmal nocturnal hemoglobinuria;Rosse,1995

3. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor;Yeh;J Clin Invest,1994

4. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria;Takeda;Cell,1993

5. Paroxysmal nocturnal hemoglobinuria is caused by somatic mutations in the PIG-A gene;Bessler;EMBO J,1994

Cited by 402 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms;Drug Discovery Today;2024-09

2. Complement C3 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with suboptimal response to C5 inhibitor therapy;Oncohematology;2024-09-01

3. Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis;Blood;2024-07-11

4. Targeted management of coexistent severe thrombophilias—A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiency;eJHaem;2024-07-11

5. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition;American Journal of Hematology;2024-06-17